Biocept And Rosetta Genomics Collaborate To Evaluate microRNAs From Circulating Tumor Cells
October 13, 2014 at 08:31 AM EDT
Biocept, Inc. (Nasdaq: BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor ...